

A questionnaire was sent to an 8-member panel of experts (8 professors in related fields) to assess the consistency of the two English versions. This original version was translated into Chinese and then retranslated into English by a third party unfamiliar with the test.

We were granted permission to translate and revise the English version of the MoCA from its original author in March 2010. This study assessed the reliability and validity of the MoCA-CS in a sample of ischemic cerebrovascular disease patients in Hunan Province, China, and explored the optimal cutoff scores for detecting VCI-ND and VD. The Changsha version of the MoCA (MoCA-CS) is a Chinese version of MoCA that was modified from the original MoCA (English version) by our research team based on mainland cultural, linguistic, and population characteristics. Indeed, the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network (NINDS-CSN) VCI harmonization standard recommended the MoCA as a 5-min protocol for detecting VCI. In contrast, the MoCA includes executive function and attention (among many different cognitive domains), making it an ideal test for screening VCI. Increasingly, studies have found that the MMSE lacks testing items related to executive function, which makes it unsuitable for detecting VCI (especially VCI-ND). Studies have shown that cognitive deficits associated with VCI can cover all cognitive domains, with executive function and attention being two of the most sensitive domains for detecting VCI. VCI can be divided into two stages: VCI-no dementia (VCI-ND) and vascular dementia (VD). Vascular cognitive impairment (VCI) refers to all forms of mild-to-severe cognitive impairment associated with and presumed to be caused by cerebrovascular disease. In a period of 6 years, the original MoCA has expanded from two versions (English and French) to more than 30 different versions, has become utilized in many more countries, and is now the most popular cognitive screening tool for detecting MCI.Ĭerebrovascular disease is the second most common cause of acquired cognitive decline and dementia. These patients usually score within the normal range on the most widely used cognitive screening tool, the Mini-Mental State Examination (MMSE). The Montreal Cognitive Assessment (MoCA ) is a cognitive-screening test which was recently introduced to detect patients with mild cognitive impairment (MCI).
